PHGDH mediated serine biosynthesis metabolism suppresses vascular calcification

Read full text Summarise with VIRAT
Authors: Liao Tan, Jie Liu, Ruizheng Shi, Yubo Liu
Cited by: 0
References: 38

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

BACKGROUND: Vascular calcification is a major pathological process driving cardiovascular morbidity and mortality, yet effective therapies are lacking. This study aims to identify novel causal plasma proteins and therapeutic targets for vascular calcification through an integrative multi-omics approach and to further explore their functional roles and regulatory mechanisms in vascular calcification. METHODS: We performed a high-throughput Mendelian randomization (MR) analysis using protein quantitative trait loci from two large-scale proteomic studies (deCODE and UKB-PPP) as genetic instruments. Summary-level data for vascular calcification were obtained from genome-wide association studies. Candidate proteins underwent rigorous sensitivity analyses, colocalization, and external replication. Transcriptomic data were analyzed to assess expression changes in calcified vascular smooth muscle cells. Functional validation and mechanism exploration was conducted in high-phosphate-induced human aortic smooth muscle cells (HASMCs) and a 5/6 nephrectomy mouse model of vascular calcification using siRNA, overexpression plasmids, and the pharmacological inhibitor NCT-503. CLINICAL TRIAL NUMBER: Not applicable.

Fields of Study & Subjects

Parathyroid Disorders and Treatments Dermatological and Skeletal Disorders Genetic Associations and Epidemiology

Publication details

Journal / source
Biology Direct
Volume
21
Issue
1
Publication date
23 March 2026
Language
EN